| Literature DB >> 12429397 |
Raúl de la Fuente-Fernández1, Anthony G Phillips, Mariangela Zamburlini, Vesna Sossi, Donald B Calne, Thomas J Ruth, A Jon Stoessl.
Abstract
Using the ability of [11C]raclopride to compete with dopamine for D(2)/D(3) receptors, we investigated by positron emission tomography the effect of placebo (saline) injection on dopamine release in the ventral striatum of patients with Parkinson's disease. We found evidence for placebo-induced dopamine release of similar magnitude to that reported in healthy volunteers after amphetamine administration. However, in contrast to the dorsal striatum, there were no differences in [11C]raclopride binding potential changes between patients who experienced the reward (those who reported placebo-induced clinical benefit) and those who did not. We conclude that the release of dopamine in the ventral striatum (nucleus accumbens) is related to the expectation of reward and not to the reward itself. These observations have potential implications for the treatment of drug addiction. Copyright 2002 Elsevier Science B.V.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12429397 DOI: 10.1016/s0166-4328(02)00130-4
Source DB: PubMed Journal: Behav Brain Res ISSN: 0166-4328 Impact factor: 3.332